We are live on
!
Find out more
ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
0 hedge funds and large institutions have $0 invested in Adamas Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% less funds holding
Funds holding: 63 → 0 (-63)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $148M → $0 (-$148M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 62
Holders
–
Holders Change
-63
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
62
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$26.8M |
| 2 |
AC
Armistice Capital
New York
|
-$19.6M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$19.2M |
| 4 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$12.7M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$8.67M |
